Company page
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. is a public company traded under the ticker ALLO in the American market. The company has a market capitalization of approximately $690 million. Allogene focuses on developing innovative cell therapies for cancer treatment.
- Ticker
- ALLO:NASDAQ
- Asset type
- Stock
- Market cap
- $690.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD